DK1889629T3 - Stabil formulering omfattende en kombination af et fugtsensitivt stof og et andet stof og fremgangsmåde til fremstilling deraf - Google Patents

Stabil formulering omfattende en kombination af et fugtsensitivt stof og et andet stof og fremgangsmåde til fremstilling deraf

Info

Publication number
DK1889629T3
DK1889629T3 DK06253596T DK06253596T DK1889629T3 DK 1889629 T3 DK1889629 T3 DK 1889629T3 DK 06253596 T DK06253596 T DK 06253596T DK 06253596 T DK06253596 T DK 06253596T DK 1889629 T3 DK1889629 T3 DK 1889629T3
Authority
DK
Denmark
Prior art keywords
substance
combination
moisture sensitive
preparation
stable formulation
Prior art date
Application number
DK06253596T
Other languages
Danish (da)
English (en)
Inventor
Michael Fox
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of DK1889629T3 publication Critical patent/DK1889629T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06253596T 2006-07-10 2006-07-10 Stabil formulering omfattende en kombination af et fugtsensitivt stof og et andet stof og fremgangsmåde til fremstilling deraf DK1889629T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06253596A EP1889629B1 (de) 2006-07-10 2006-07-10 Stabile Zubereitung enthaltend eine Kombination aus einer feuchtigkeitsempfindlichen aktiven Substanz und einer zweiten aktiven Substanz und Verfahren zur Herstellung der Zubereitung.

Publications (1)

Publication Number Publication Date
DK1889629T3 true DK1889629T3 (da) 2008-12-15

Family

ID=37074674

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06253596T DK1889629T3 (da) 2006-07-10 2006-07-10 Stabil formulering omfattende en kombination af et fugtsensitivt stof og et andet stof og fremgangsmåde til fremstilling deraf

Country Status (6)

Country Link
EP (1) EP1889629B1 (de)
AT (1) ATE406173T1 (de)
DE (1) DE602006002514D1 (de)
DK (1) DK1889629T3 (de)
ES (1) ES2313578T3 (de)
PT (1) PT1889629E (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006344A (en) * 1989-07-10 1991-04-09 E. R. Squibb & Sons, Inc. Fosinopril tablet formulations
IS1935B (is) * 2002-03-19 2004-06-16 Actavis Group Hf. Fósínópríl lyfjasamsetning
EP1545471A1 (de) * 2002-08-02 2005-06-29 Ranbaxy Laboratories, Ltd. Lagerstabile tabletten aus fosinopril-natrium

Also Published As

Publication number Publication date
PT1889629E (pt) 2008-10-20
ATE406173T1 (de) 2008-09-15
ES2313578T3 (es) 2009-03-01
DE602006002514D1 (de) 2008-10-09
EP1889629B1 (de) 2008-08-27
EP1889629A1 (de) 2008-02-20

Similar Documents

Publication Publication Date Title
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
NO20064584L (no) Tetrahydropyridoindolderivater
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
UA95199C2 (en) Aqueous formulation of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
NO20073601L (no) Immunresponsmodifikator-skumformuleringer
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
EA200800360A1 (ru) Формуляции с высоким содержанием лекарства и дозированные формы
DK1810676T3 (da) Levetiracetam formuleringer og fremgangsmåder til deres fremstilling
WO2006002077A3 (en) Stable pharmaceutical formulations of benzimidazole compounds
NO20076448L (no) Novel piperidine carboxylic acid amide derivatives
BRPI0821373A2 (pt) Composições farmacêuticas contendo ao menos um princípio ativo protéico protegido de enzimas digestivas
WO2007090661A3 (en) Active substance combination comprising azolylcarbinol compounds
DE602005020314D1 (de) Bicyclononen-derivate als renin-inhibitoren
NO20083183L (no) Fast farmasoytisk sammensetning inneholdende irbesartan
NO20065898L (no) 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner
TW200628468A (en) Bicyclononene derivatives
CL2009001183A1 (es) Formulación farmacéutica sólida que comprende a) cilostazol, b) 10 a 90% de un almidón pregelatinizado c) uno o más tipos de ingredientes entéricos, y d) un ácido orgánico.
DK1818048T3 (da) Farmaceutiske formuleringer af alifatiske aminpolymerer og metoder til deres fremstilling
DK1889629T3 (da) Stabil formulering omfattende en kombination af et fugtsensitivt stof og et andet stof og fremgangsmåde til fremstilling deraf
NO20085423L (no) stabil formulering omfattende fuktighetsfolsomt legemiddel og fremgangsmate for fremstilling derav
TW200621774A (en) Bicyclononene derivatives
TR201803451T4 (tr) Olmesartan formülasyonlari.
EA201100753A1 (ru) Композиции с пролонгированным высвобождением, содержащие производное 2-оксо-1-пирролидина
BRPI0519840A2 (pt) derivados de ácido fenilbenzóico, processos para preparação do mesmo, composições farmacêuticas compreendendo-os e usos terapêuticos dos mesmos
NO20090609L (no) Stabilt preparat omfattende en kombinasjon av et fuktighetsfolsomt legemiddel og et andre legemiddel, samt fremgangsmate for dets fremstilling